Phocas Financial Corp. Intercept Pharmaceuticals, Inc. Transaction History

Phocas Financial Corp.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$24.48 - $42.47 $739,467 - $1.28 Million	-30,207 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$39.09 - $53.44 $38,699 - $52,905	990 Added 3.39%	30,207 $1.25 Million
Q2 2020 Aug 24, 2020	BUY	$46.7 - $92.04 $551,760 - $1.09 Million	11,815 Added 67.89%	29,217 $1.4 Million
Q1 2020 May 15, 2020	SELL	$48.35 - $118.68 $73,105 - $179,444	-1,512 Reduced 7.99%	17,402 $1.1 Million
Q4 2019 Feb 14, 2020	BUY	$57.36 - $124.1 $1.08 Million - $2.35 Million	18,914 New	18,914 $2.34 Million

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Phocas Financial Corp., based on Form 13F filings with the SEC.

Stay updated on Phocas Financial Corp. with notifications on news.